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Stem cells can stay quiescent for a long period of time or proliferate and differentiate into
multiple lineages. The activity of stage-specific metabolic programs allows stem cells to
best adapt their functions in different microenvironments. Specific cellular phenotypes
can be, therefore, defined by precise metabolic signatures. Notably, not only cellular
metabolism describes a defined cellular phenotype, but experimental evidence now
clearly indicate that also rewiring cells towards a particular cellular metabolism can drive
their cellular phenotype and function accordingly. Cellular metabolism can be studied
by both targeted and untargeted approaches. Targeted analyses focus on a subset of
identified metabolites and on their metabolic fluxes. In addition, the overall assessment
of the oxygen consumption rate (OCR) gives a measure of the overall cellular oxidative
metabolism and mitochondrial function. Untargeted approach provides a large-scale
identification and quantification of the whole metabolome with the aim to describe a
metabolic fingerprinting. In this review article, we overview the methodologies currently
available for the study of in vitro stem cell metabolism, including metabolic fluxes,
fingerprint analyses, and single-cell metabolomics. Moreover, we summarize available
approaches for the study of in vivo stem cell metabolism. For all of the described
methods, we highlight their specificities and limitations. In addition, we discuss practical
concerns about the most threatening steps, including metabolic quenching, sample
preparation and extraction. A better knowledge of the precise metabolic signature
defining specific cell population is instrumental to the design of novel therapeutic
strategies able to drive undifferentiated stem cells towards a selective and valuable
cellular phenotype.
Keywords: stem cell, cell metabolism, neural stem cell (NSC), indiced Pluripotent Stem Cells (iPSCs), metabolic
flux analysis (MFA), metabolomics (OMICS), cell reprogramming, pharmacology
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INTRODUCTION
The intertwining relationship between cell energy metabolism
and function has been reported since the early 1960s (Cohn
and Hirsch, 1960; Oren et al., 1963). Increasing evidences
suggest that cells adopt distinct metabolic signatures in different
functional conditions, thus leading to cell metabolism as
an emergent research field (Pearce and Pearce, 2013) and
creating novel exciting opportunities for future therapeutic
applications (O’Neill et al., 2016).
Cell metabolism describes the biochemical phenotype of the
cell. However, it is not a fixed cell property since it undergoes
continuous and highly dynamic modifications to adapt cells
to changes in energy requirement, fuel availability, biomass
production, reductive-oxidative status, post-translational and
epigenetic settings. Moreover, cell metabolism connects the
extracellular microenvironment (i.e., availability of nutrients,
such as glucose and oxygen) with the functional cellular need
(for example, cell growth, migration, or synapse formation;
Formaggio et al., 2010; Dibble and Manning, 2013; Ochocki and
Simon, 2013; Yuan et al., 2013).
Players of cell metabolism consist of substrates, enzymes,
cofactors, reaction products and by-products, all involved
in biochemical reactions. The quantity, velocity and
compartmentalization of these reactions specify cellular
functions. Importantly, cell metabolism should not be
considered independently of the genetic and proteomic
cellular context. Indeed, all these features converge to define
the final cell phenotype and function (Metallo and Vander
Heiden, 2013). A very simple way of describing the cellular
status at a given time would be to consider it as the result
of a one-way chain of events: gene expression determines
protein content that in turn defines the metabolic status
of the cell. However, it has been well characterized that all
of these events are closely and intricately regulated, and
proteins control both DNA transcription and metabolic
reactions. More recently, the capability of metabolites to
regulate gene expression, as well as protein activity and
distribution, has been described (Lu and Thompson, 2012;
Sperber et al., 2015). Consequently, to fully define and
potentially modulate cellular activities, a multilayer picture
of the cellular phenotype should include the characterization of
cell metabolism, in addition to the study of gene expression and
protein function.
Not surprisingly, cells in different conditions, such as
quiescent stem cells (SCs), amplifying precursors and
differentiated cells, show dramatic changes in their cellular
metabolism (O’Neill et al., 2016). However, unlike other cells
in the tissues, SC population are usually rare and intermingled
with other cell types of the niche. Moreover, in the stem cell
niche quiescent SC, expanding precursors and differentiated
cells coexist together, and the proportion of these SC phenotypes
may vary depending on the tissue condition (e.g., health or
disease). Therefore, there are specific constraints imposed
by working with stem cells. Due to their rare distribution,
metabolic analysis obtained from the whole tissues may not
be always representative of the SC metabotypes. On the other
hand, classic available methods to sort specific SC population
cannot entirely be applied since both fluorescence activated
(FACS) and immunomagnetic cell sorting requires too long
time for sample preparation and processing prior to metabolic
quenching, the time in which cells undergo mechanical stress
and quickly change their metabolism. The recent development
of single-cell metabolomics, multimodal in vivo imaging and
novel biosensors, that allows real-time metabolism at single
cell level in living samples, may offer new opportunities to
specifically describe stem cell metabolism. Hence, appropriate
methods need to be applied for the study of SC metabolism. In
this review article, we will provide an up-to-date overview of the
different techniques for the investigation of cellular metabolism
of SCs, highlighting the peculiarities, strengths and limitations
of each methodology.
Understanding cell metabolism of SCs and of their
differentiated progenies provides unique insights for the
identification of molecular hubs capable of integrating the
multiplicity of signaling underlying these processes, and driving
stem cell quiescence, expansion and differentiation. Rewiring cell
metabolism is nowadays an attractive and innovative strategy
for developing novel and effective drugs able to restore stem cell
function, and eventually, help to heal the pathological phenotype.
CELL METABOLISM OF
UNDIFFERENTIATED AND
DIFFERENTIATED SCs
During embryogenesis, SCs symmetrically expand their number,
blood perfusion is still incomplete, and proliferating cells
relay mostly on glycolysis for their metabolic needs (Ito and
Suda, 2014; Gu et al., 2016). Subsequently, a proportion of
cells undergo differentiation, and this process often implies an
increase in their metabolic needs (Prigione et al., 2015). SC
differentiation generally requires morphological and functional
changes. As an example, during development, neural stem
cells (NSCs) self-renew, expand the number of committed
progenitors, migrate to the cortex, and differentiate into mature
neurons that functionally integrate within the tissue (Bifari
et al., 2017a; Pino et al., 2017; Kempermann, 2019). NSCs
persist in selected regions of the adult mammalian brain
(Bifari et al., 2009, 2015; Decimo et al., 2011; Bond et al.,
2015). NSCs have multipotent differentiation potentials and
differentiated cells greatly modify their cellular morphology
(Decimo et al., 2012a,b). Differentiating oligodendrocytes
progressively expand cellular branching, reaching a mean
of about 20 branching/cell (Butt et al., 1994; Dolci et al.,
2017). All these differentiation stages are accompanied
by specific changes in cellular metabolism (Lange et al.,
2016; Knobloch and Jessberger, 2017; Beyer et al., 2018).
Neuronal differentiation, synaptic transmission, generation
and conduction of action potentials are highly metabolic-
demanding cellular activities (Laughlin et al., 1998). Accordingly,
differentiated neuronal cells need to adapt their metabolism
towards a more efficient oxidative metabolism (Lange
et al., 2016; Beckervordersandforth et al., 2017). Indeed,
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the adult brain accounts for more than 20% of the body
oxygen consumption.
Increasing evidence demonstrate that plasticity in energy
metabolism is a crucial regulator in shaping the balance
between self-renewal potential and lineage specification (Folmes
et al., 2012; Ito and Suda, 2014; Prigione et al., 2015). In
particular, a proper quality control of mitochondrial function
has been recently highlighted as a key factor in SC maintenance
and commitment (Shyh-Chang et al., 2013). In order to
demonstrate hematopoietic SC (HSC) repopulating capacity,
HSCs are kept in a quiescent state, where they exhibited
higher glycolysis rate and lower mitochondrial respiration
than committed progenitor cells (Chandel et al., 2016; Roy
et al., 2018). The disruption of this metabolic checkpoint
leads to the loss of quiescence and to a reduced regenerative
capacity, and directs HSCs towards lineage commitment where
the displacement to mitochondrial metabolism (mitochondrial
oxidative phosphorylation) is essential, in order to rapidly
respond to the increased demand of energy (Vannini et al.,
2016). Importantly, the mammalian Target Of Rapamycin
(mTOR), one of the most important regulators of mitochondrial
function via the increase in mitochondrial biogenesis, is
required for the active cycling of HSCs losing stemness
(Chen et al., 2008). Mitochondria also act as the leading
site for the production of Reactive Oxygen Species (ROS),
and ROS accumulation finally contributes to the defective
functioning of HSCs and their loss of stemness. Accordingly,
ROS clearance exhibits a positive effect on HSC recovery of
stemness (Chandel et al., 2016; Roy et al., 2018). In this
scenario, autophagy, or rather mitophagy, a self-degradative
process involved in the energy balance (Mizushima and
Komatsu, 2011), plays an essential role in the reversion of
metabolically active HSCs to quiescence by clearing healthy
but active mitochondria, thus preventing the induction of
(epi) genetic programs that lead to HSC commitment, and
thereby supporting the maintenance of healthy hemeatopoiesis
(Riffelmacher and Simon, 2017; Jin et al., 2018).
Alterations of the redox state are also crucial in the regulation
of proliferation and differentiation of neural progenitors.
Mitochondrial dynamics regulate stem cell fate by modifying
ROS signaling, which in turn increases the nuclear factor
erythroid 2–related factor 2 (NRF2) gene expression promoting
neuronal differentiation (Beckervordersandforth et al., 2017).
Furthermore, fatty acid oxidation (FAO) is specifically
upregulated in quiescent neural SCs (Folmes et al., 2012),
and it has also been involved in the control of neural SC
proliferation (Shyh-Chang et al., 2013).
Although the maintenance of SCs and the generation of
differentiated lineages are undoubtedly conditioned by cellular
metabolism, to date, less is known about the regulation of
the differentiation potential of SCs by exogenous nutrient
availability (glucose, glutamine and fatty acids, but also lipids
and nucleotides) and by their intracellular pathways. The glucose
transporter 1 (Glut1) and the glutamine transporter ASCT2 are
highly upregulated during HSC erythroid differentiation. As
a matter of fact, downregulation of ASCT2 or the block of
glutamine metabolism abrogate HSC erythroid differentiation,
diverting towards a myeloid fate (Montel-Hagen et al., 2008;
Pouzolles et al., 2016).
Notably, metabolic fuels do not solely function as sources
of ATP (Folmes and Terzic, 2016; Oburoglu et al., 2016)
as well as cellular metabolism not merely describes how the
cell gets its energy. The specific metabolic signature of the
cell accounts for its unique phenotype and functions. Fuel
sources actively impact on cell signaling and transcription
(Yuan et al., 2013; Saxton et al., 2016; Bifari and Nisoli, 2017;
Bifari et al., 2017b) by integrating metabolic and epigenetic
signals (Ochocki and Simon, 2013). For example, the glycolytic
metabolite phosphoenolpyruvate stimulates the transcriptional
activity of the Nuclear Factor of Activated T cells (NFAT)
that regulates Mitofusin 2, a key player in the mitochondrial
fusion, trafficking and turnover, modulating the maintenance
of HSCs with lymphoid, but not myeloid, lineage potential (Ho
et al., 2015; Luchsinger et al., 2016). Similarly, reprogramming of
neuronal metabolism has been shown to greatly protect the brain
from stroke (Quaegebeur et al., 2016).
Somatic cell reprogramming to pluripotent state is also
associated with a drastic rewiring of cellular metabolism. The
metabolic shift to glycolysis is an obligatory step for somatic cell
reprogramming (Folmes et al., 2011), and inhibition of glycolysis
prevents the reprogramming of the induced pluripotent stem
cells (iPSCs). Interestingly, early after reprogramming, an
oxidative phosphorylation burst is also required. Therefore, to
successfully go to the pluripotent state, iPSCs synergistically
enhance both glycolysis and oxidative phosphorylation. Several
factors appear to be associated with this reprogramming-
induced hybrid energy metabolism. Following reprogramming,
the up-regulation of Zic3 and Esrrb genes activate glycolytic
metabolism independently of hypoxia-inducible factors, while
Esrrb, but not Zic3, mediates oxidative phosphorylation
activation (Sone et al., 2017). Up-regulation of estrogen-related
receptors is also involved in the oxidative phosphorylation burst
in both human and mouse iPSCs (Kida et al., 2015).
In conclusion, increasing evidence demonstrate that SCs in
different functional states adopt distinct metabolic properties
and signatures, and that imposing specific cellular metabolism
can drive SC self-renewal and differentiation (Quaegebeur et al.,
2016). A deeper understanding of the molecular mechanisms
underlying metabolic control of the SC properties is therefore of
great biological interest. More importantly, improved knowledge
on cell metabolism will be critical for the development of
novel exciting therapeutic strategies targeting SC self-renewal,
proliferation and differentiation for the regenerative medicine
(Decimo et al., 2012a; Shyh-Chang et al., 2013; Ito et al., 2019).
METHODS TO STUDY SC METABOLISM:
A USER’S GUIDE
Different Experimental Approaches for
Different Questions
Understanding the intracellular metabolism of SCs is a pivotal
task to clarify mechanisms that govern their maintenance,
proliferation, migration and differentiation in response to
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biological stimuli. Resolving heterogeneity between different
cellular phenotypes is still a challenging task that requires high
sensitive methodologies. In this contest, Nuclear Magnetic
Resonance (NMR)- and mass spectrometry (MS)-based
methodologies are the preferred choices due to their ability
to generate high-throughput data from a limited volume of
sample with relatively low concentrated metabolites.
Two main approaches can be used for studying stem cell
metabolism: the untargeted and the targeted metabolic analyses
(Figure 1). Untargeted metabolic assessment implies the study of
all the metabolites that can be measured, thus giving an overall
description of the metabolic state of samples. This metabolic
fingerprint provides an accurate description of the metabolite
abundance present at a given time inside the cell. Targeted
metabolic analysis focuses on the study of a subset of metabolites
possibly involved in a specific pathway. In addition, the overall
assessment of the intracellular oxygen consumption rate (OCR)
gives valuable information on the oxidative metabolism and
mitochondrial function.
The investigation of the metabolic dynamics, i.e., metabolic
flux analysis, is a complementary approach to the quantification
of metabolites and it is often required to fulfill the missing
information that cannot be provided by metabolic fingerprint.
In fact, the profile of metabolites is very powerful in describing
differences in pathways and nodes among samples, but it
does not explain the biological mechanism(s) responsible for
these differences. As an example, the metabolic profile can
show a drastic difference in the concentration of a metabolite
between two different experimental conditions. However,
without the study of the dynamic fluxes, it is not possible
to predict whether the change is due to a modulation in the
biosynthesis, to degradation of the metabolite, to a different
mobilization from segregated storage or to the activation of
alternative pathways.
Available techniques effectively analyze the cellular
metabolism of homotypic cell population in vitro or of
tissues ex vivo. Although encouraging attempts have been
made, the assessment of the cellular metabolism at single cell
level remains not entirely resolved. Furthermore, the study of
the in vivo cellular metabolism remains challenging. The use
of detectable probes in living tissue allows the evaluation of
the cellular metabolic activity. Although the specificity and
sensitivity of the in vivo techniques are remarkably high, the
spatial resolution (0.12 mm; Blüml and Panigrahy, 2013; Shah
et al., 2013; Stucht et al., 2015) is too large for resolving the
metabolism of single cells.
Nuclear Magnetic Resonance (NMR) vs.
Mass Spectrometry
Two major technologies are used for metabolomics analysis,
i.e., NMR and MS. The two platforms have different limits
and advantages deeply discussed elsewhere in the literature
(Ellis et al., 2007; Pan and Raftery, 2007). The critical issue
regarding SCs is the availability of biomaterial for analysis and
the related sample volumes and concentrations. MS analysis
is an obliged choice for the aforementioned limits, due to its
higher sensitivity compared with NMR, but it does not imply
that NMR analysis should be avoided. In fact, the two methods
are very comparable and complementary with a highly different
coverage. There are limited examples of concomitant use of
both techniques in metabolomics, but the scientific community
is recognizing more and more the need to complement the
technical limits by coupling these two technologies online.
Although this association will probably be the method of choice
in the foreseeable future, the tools for this type of analysis,
e.g., software and hardware handling both instruments online,
and integrated data analysis, are still in their infancy or lacking.
The most popular methodology in metabolomics is based on
liquid chromatography coupled with MS. This is due to advances
in material science and instrumental precision and sensitivity. In
liquid chromatography, a major advancement was achieved by
the introduction of core-shell particle technologies (Fekete et al.,
2012). Compared with classical stationary phases, core-shell
particles have lower mass-transfer dispersion, thus resulting in
a lower height of theoretical plates and enhanced separation
efficiency. As a result, this type of stationary phase allows for
narrowing of the peak width, and as a consequence, increases
the peak intensities (Martano et al., 2014). These characteristics
are well exploited thanks to the development of chromatographic
platforms that can handle high pressure (>1,000 bars) and
are coupled to high resolution mass spectrometers that are
able to sustain a scan rate in the millisecond ranges. Of
particular interest, the ability to scale down the instrumental
platform to nanoUHPLC coupled with nanoESI-MS gives the
possibility to analyze the metabolome using a limited number
of cells per sample (commonly between 100 and 500 cells), with
high metabolic coverage. This methodology allows for further
downscaling of sample investigation to single cell analysis,
but this choice is not costless in term of metabolic coverage,
separation and sample handling, as discussed later.
Metabolic Fingerprint
Questions:
Is the stem cell population A different from the stem cell
population B? Is the stem cell population changing its phenotype
from condition X to Y? What are the main nodes and the most
relevant pathways of the cellular metabolism of a specific stem
cell population?
Metabolomics is a broad and sensitive method to detect
differences in cellular metabolic states. Notably, this metabolic
assessment is related to a very precise time and space, and
it can be considered as a snapshot of the global metabolome
of the sample analyzed. Metabolic fingerprint may provide
valuable information in understanding the impact of different
experimental conditions on the overall metabolic state of
cells or tissues. Metabolomics provides precise information
on the intra- or extra-cellular metabolite levels. However,
metabolic fingerprint does not give any indication on the
cause of the measured variations of metabolites. This is
very important to consider when planning the experiment.
If we need to study how cells or tissue modify their overall
metabolome, or more precisely the metabolite abundance
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FIGURE 1 | Schematic representation of the different experimental approaches for the study of the metabolism of stem and progenitor cells. In the left panel are
depicted the untargeted metabolic analysis, metabolic fingerprint (upper left) and single-cell metabolomics (lower left). The study of the whole metabolite content
(untargeted metabolic analysis) of the samples can be performed by using mass spectrometry (MS) and nuclear magnetic resonance (NMR). In the right panel are
figured the targeted metabolic approaches, metabolic flux analysis (upper right) and in vivo cell metabolism (lower right), which focus on the study of metabolites
possibly involved in a specific pathway. Several techniques can be applied to study targeted metabolic analysis, including MS, NMR, magnetic resonance imaging
(MRI), magnetic resonance spectrometry (MRS), positron emission tomography (PET), single photon emission tomography (SPECT), oxygen consumption rate (OCR)
and Biosensor.
of specimens, untargeted metabolomics is the gold standard
technique. Furthermore, based on the observable changes in
absolute or relative intracellular metabolite levels, we can
define the metabolic pathways and nodes that are modulated
in different specimens. What we cannot infer, however, is
the reason why the measured alterations occur. Increase in
substrate (i.e., fructose 6-phosphate) and decrease in a product
(fructose 1,6-bisphosphate) may be due to an altered enzymatic
activity (phosphofructokinase-1), as well as to an altered
consumption of the product (increase/decrease glycolysis) or
excessive production of the substrate (hexokinase activity).
To further understand the biological reasons from which
the differences stem, complementary technique assessing the
metabolic dynamics (metabolic flux analysis) should be used.
Several issues need to be taken into account when designing
the experimental plan for metabolic investigation. Sorting the
desired cell population is arguably the most critical step in
this type of analysis. Especially for metabolites with very fast
turnover rate and low in abundance, the time required for sample
preparation negatively influences the biological readout. The
speed of sampling becomes even more critical when planning
the investigation of kinetic profile using labeled standards, which
require a tight sampling time to avoid data dispersion.
Metabolic Quenching
In in vitro experiments, the selection of the proper sampling
method is linked to the type of culture condition selected,
i.e., adherent or in suspension cultures (Figure 2). SCs can
be grown as spheroids. Although there are no protocols
specifically designed for the investigation of the metabolism of
SCs in this condition, similar protocols originally developed
for bacterial culture are easily adaptable to this purpose. Fast
filtration, on filters followed by the transfer of the filter in cold
organic quenching solution, as developed by Rabinowitz’s group,
provides a robust pipeline and has been successfully used in
this type of analysis (Bennett et al., 2008; Abu Dawud et al.,
2012). In this approach, batch culture is slowly dripped onto
a nylon filter membrane placed on the top of a vacuum flask,
with a moderate-week vacuum applied in order to minimize
mechanical stress. Additional washing step can be applied in
this stage to further remove medium residues. Filters are then
transferred in a separated well containing a quenching solution,
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FIGURE 2 | Graphic summary of recommended quenching workflows for SCs. Schematic representation of the quenching methods for cell in suspension by fast
filtration adapted from Bennett et al. (2008) (A) and by cold quenching prior to sample collection as described by Sellick et al. (2009) (B). In Panel (C) is outlined the
quenching methods for adherent SCs by culturing cells on glass coverslips as described by Martano et al. (2015).
and metabolites are extracted for analysis. The method is also
suitable for profiling the kinetic flux using labeled substrates
(Yuan et al., 2008). Fast filtration avoids the delay that would be
introduced by typical harvesting procedures based on pelleting
by centrifugation. A major concern against pelleting is due to
the time required for the entire procedure prior to metabolic
quenching, time in which the cells undergo mechanical stress.
In that case, the extracted metabolites will likely represent the
response of the cells to the harvesting procedure rather than the
original biological phenotype. On the other hand, pelleting can
be efficiently used if the metabolism is already quenched without
damaging the cell integrity as in the method described by Sellick
et al. (2009). The protocol was developed for the investigation
of Chinese hamster ovary and mouse myeloma NS0 cell lines
and utilized a quenching solution composed by 60%methanol in
ammonium bicarbonate, added to avoid membrane disruption,
and maintained at −40◦C. This method does not require the use
of filters and the procedure is very straightforward, but the major
drawback is that it cannot be easily adapted for dynamic labeling
profile analysis.
In adherent NSCs cultivated on coated surface, e.g., poly-L-
lysine coating, similar issues need to be taken into account. In this
case, cell harvesting should be avoided (e.g., trypsinization and
pelleting) in favor of simultaneous quenching, and extraction in
cold solvents. The limiting step when working with adherent cells
is that a fast and complete removal of culture medium is required
prior to quenching and extraction. A strategy to overcome this
issue is presented in the protocol developed by the Vorholt
group, in which cells were grown on glass coverslips (Martano
et al., 2015), as it is conventionally done for experiments in
microscopy. In this protocol, coverslips containing the cell
culture are removed from the original medium, dipped and
carefully tilted in a separated beaker under a steam of water,
and immediately transferred in a cold quenching solution. This
allows the fast removal of the cells of interest from the original
medium and the subsequent fast wash in a steam of distilled
water before quenching, with a minimal perturbation of the cell
culture. The same procedure can be applied when performing
dynamic labeling profile analysis by replacing the distilled water
with a minimal medium without the metabolite of interest,
thus avoiding the stochastic influence of the carry-over from
initial medium.
Ex vivo experiments and metabolic profiling from tissues
are probably the most challenging approach to work with.
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Strategies such as heat-stabilization and snap-freezing of the
tissue of interest after dissection are usually avoided due to
the effects of post-mortem degradations (Mulder et al., 2016).
Instead, in situ freezing or funnel freezing are preferred,
because they can be performed under anesthesia while
the tissue maintains blood flow and oxygenation (Mulder
et al., 2016), thus avoiding perturbation of the metabolic
state. After the metabolism has been quenched, a selected
micro-dissected region of interest can be sampled. The
challenge is then to choose the proper analytical technique
to analyze the selected region. The major concern relates to
the under representation of SCs in the tissues. Therefore,
data obtained from homogenized tissues, although the
selected tissue may be enriched with SCs, will not be
representative of the metabotype that those cells exhibit.
Other approaches, based on mass spectrometry imaging (MSI)
and single cell analysis may be applied instead, as discussed in
later paragraphs.
Sample Preparation and Extraction Tips
Another critical step in performing metabolic profile analysis is
the selection of the extraction solvent in which the metabolites
are solubilized before analysis. Due to the heterogeneity of
chemical-physical properties of the metabolome, which includes
highly hydrophilic as well as hydrophobic compounds, it is
difficult, if not impossible, to achieve the complete metabolome
extraction using a single technique. Second, the extraction
procedure must be compatible with the analytical methods
selected for analysis and should avoid the artificial production
of compounds that alters the original metabolite concentration.
A classic example of generated artifacts is the ratio between
ATP, ADP, AMP, analyzed by LC-MS in positive mode
with the most common mobile phase i.e., water, acetonitrile
with 0.1% formic acid. In this case, the acid hydrolysis will
promote the dephosphorylation of the metabolites, which will
be converted in the precursors (e.g., ATP will turn in ADP,
and ADP in AMP), and therefore, the analysis will return
an overestimation of less phosphorylated compound at the
expenses of highly phosphorylated ones. Commonly, a mixture
of methanol, acetonitrile and water can be used to both cold
quench the metabolism and extract the metabolites of interest.
The ratio between the solvents can be arranged based on the
hydrophobicity/hydrophilicity of the metabolites of interest.
The organic content has the advantage of promoting protein
precipitation and sample extraction in one-step but causes
instability in reverse-phase chromatography. This limit can
be circumvented by solvent exchange where the samples are
dried e.g., lyophilized, and samples are re-dissolved in the
appropriate solvent. This also gives the possibility of storing
the samples of interest for prolonged periods but has the
disadvantage of introducing potential perturbation/degradation
in oxygen-reactive metabolites. Therefore, while a generalized
approach cannot be drawn, a wise choice of the available
options must be taken in to account based on the species of
interest. For example, for labile compounds such as Acetyl-CoA,
the presence of acetonitrile and formic acid may compromise
the compound recovery. In that case, after quenching, a
mild solvent exchange using lyophilization or nitrogen steam
followed by aqueous extraction can enhance extraction efficiency
for Acetyl-CoA.
Single-Cell Metabolomics
Questions:
What is the heterogeneity of stem cells? Are the experimental
conditions affecting the cell phenotype in a different way
and/or time?
Resolving the heterogeneity of cell populations is an attractive
field in several omics discipline including metabolomics. The
possibility to scale-down the analysis down to a single cell is
of particular importance in the field of cancer research, where
cancer SCs subpopulations are very likely responsible for the
origin of metastatic phenotypes and contribute to chemotherapy
resistance and relapse (Tu, 2010; Zenobi, 2013). Despite the
recent innovations in single cell metabolic analysis, the major
threat not entirely fixed yet is the time required for sampling.
Metabolism is fast and dynamic and keeping cells in their natural
environment as much as possible before sample processing
remains the most critical aspect of analysis. Methods based
on the cultivation of isolated cells are suffering from the
artificial environment, which is projected into the metabolic
profile. Few methods allowing single cell resolution in MS have
been reported in the latest years. Initially, successful results
were achieved exploiting very large cells, such as neurons in
the peripheral nervous system, using capillary electrophoresis
coupled with mass spectrometry (CE–MS; Nemes et al., 2013).
This method was further expanded by coupling off-line patch
clamp electrophysiology and CE-MS, and metabolic analysis
(Aerts et al., 2014). However, as other methods were developed
for this purpose, the size of the interested cell represents
a limitation, and unfortunately, due to their small number,
SCs often fall below the minimum analyzable size. In the
latter case, limited suitable methods have been reported in
the literature. One of these approaches has been developed
by the Masujima’s group and is named Live Single Cell Mass
Spectrometry (LiveSCMS; Mizuno et al., 2008). This method
used nanotips, which can be handled to collect the cytosol of
a selected cell under the microscope, the nanotips are then
mounted as emitters for MS analysis using a nanoESI source.
This method allows working with adherent cells with the size
limit linked to the internal diameter of the selected nanotips
i.e., 10 µm. Major drawbacks of this methodology are linked
to the complete manual sampling of the specimen of interest.
Another suitable method, recently published, combines different
techniques, such as Fluidic-force Microscopy (FluidFM) and
MALDI-MS, for analysis (Guillaume-Gentil et al., 2017). A
major advantage compared to LiveSCMS resides in the ability
to trace the sampling using atomic force microscopy, which
gives real-time information on the position of the tip. After
sampling, the cell content can be released on microarrays for
mass spectrometry (MAMS) and analyzed with MALDI-MS.
Both LiveSCMS and FluidFM-MS have the advantage of the
ability to work at a single cell level, with high metabolic coverage
without retrieving the target cells from their environment prior
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to sampling, but are limited by the time required for sampling.
Complementary to those approaches, MSI can be used down to
subcellular space with the possibility of analyzing high number of
cells with a limited timeframe, but with a limit in the number of
inspected metabolites (Kompauer et al., 2017).
Data Normalization
Another challenging aspect in the metabolomic analysis of
SCs is the choice of data normalization and standardization,
which is highly dependent on the selected methodology. In this
regard, single cell untargeted metabolomics may be considered
the most reliable approach. In fact, in that case, the number
of cells used in the dataset is known, and the outcome from
the metabolomics analysis can be used to standardize the
sample, e.g., by dividing for the sum of intensity of all the
detected metabolites in order to minimize technical variations.
Untargeted analysis on bulk cells populations requires the
introduction of constrains for data normalization. A common
approach is to normalize the metabolome with the total protein
content. This approach is particularly convenient with cold
organic extraction solutions, in which proteins are insoluble and
can be collected by centrifugation, thus efficiently separating the
proteome in the pellet from the metabolome in the supernatant,
while summed intensities of metabolites can still be used to
minimize technical errors. However, not all the workflows allow
the evaluation of protein content. Moreover, the total amount
of protein per cell is largely influenced by the cell size, and
therefore, not applicable for SCs analysis with different grades
of differentiation. When none of these options are available,
i.e., in targeted analysis where total protein content cannot
be determined or utilized, another possibility is to relay on
housekeeping metabolites (Mizuno et al., 2017). Their selection
heavily depends on experimental conditions. Unfortunately, due
to the high networking of metabolic pathways, it is impossible
to predict whether a metabolite will be indirectly influenced
from the experimental conditions. Therefore, the stability of
the selected normalizer needs to be empirically evaluated. For
example, we can consider an experimental condition in which
the energetic state of SCs is perturbed. In this example, ATP,
often used as normalizer, is unsuitable for this scope. However,
it is worth noting that the vast majority of metabolites are
transformed into each other through biochemical reactions and
ATP is not an exception. In that case, if biosynthesis and
degradation of nucleosides are unaffected by the experimental
conditions, the sum of concentrations between ATP, ADP and
AMP should remain constant and therefore can represent a
robust normalizer (Martano et al., 2016).
Metabolic Flux Analysis
Questions:
What are the specific metabolic pathway differences between
two stem cell populations? Is a specific metabolic pathway modified
by experimental condition in the stem cell population of interest?
Which is the fate of a specific metabolic substrate of the sample?
Complementary to metabolic fingerprint analysis, the study
of the dynamic between metabolites is becoming more and more
required in order to fulfill the missing information on metabolic
variations and rearrangements in the studied models. Although
metabolic flux analysis does not provide information on the
abundance of the metabolite present in the specimen, it can give
an accurate indication on the direction and rate of metabolite
conversion (flux) and whether these properties change between
experimental conditions. Changes in the metabolic flux can
be measured using radioactive tracers (De Bock et al., 2013).
Following administration to the culture medium of 5-3H-
Glucose or 3H-9, 10-palmitic acid, the quantification of H3-H2O
produced is a measure of the glycolytic and the fatty acid
oxidative fluxes. Similarly, the measure of 14C-CO2 produced by
the cell culture following the addition in the medium of 6-14C-
glucose, U-14C glutamine or 1-14C-glucose, is the quantification
of glucose, glutamine and pentose phosphate oxidations. The
quantification of all these metabolic paths allows the calculation
of the contribution of each path to the overall ATP production.
However, with radioactive tracers, it is not possible to follow the
precise fate of the substrate. The dynamic labeling profile and fate
of a substrate metabolism can be achieved by switching one of
more nutrient factors with their heavily labeled counterparts and
then follow over time the incorporation of the labeled substrate
downstream in the metabolism e.g., replace glucose with 13C
labeled glucose and follow the 13C entering in the glycolysis,
pentose phosphate pathway or TCA cycle. Following 13C labeled
substrates (tracers), the quantification of the 13C products is
performed (13C tracer analysis). Notably, different fluxes can be
studied following administration of a 13C labeled substrates by
analyzing incorporation of 13C labeled metabolites at different
time points. After seconds to minutes from the administration
of 13C glucose, we will assess glycolytic intermediates and in
the following hours, we will be able to quantify 13C labeled
metabolites branching from more distant pathways such as lipid
biosynthesis. The study of themetabolic flux of a specific pathway
requires a metabolic steady state, implying constant intracellular
metabolite levels and intracellular metabolic fluxes. Concerning
13C labeled substrate, enrichment into a givenmetabolite is stable
over time relative (isotopic steady state).
Metabolic flux analysis can be used at different experimental
stages including in vitro, ex vivo and in vivo analysis of
metabolism. Three major considerations must be taken into
account for planning at best this type of analysis, i.e., selection
of the substrate, experimental time windows, and minimization
of system perturbations. The first point strictly relates to the
core pathways of interest, and therefore, choosing the substrates
to be replaced with the labeled counterparts should reflect
the nearest entry point of the core pathway of interest. For
example, when studying gluconeogenesis, providing labeled
pyruvate or lactate will directly feed the pathway of interest
enabling more robust readouts compared with substrates, which
are more distant in metabolic terms (Jang et al., 2018). The
second point, the experimental time windows, is probably the
most difficult to predict, but the most important for a correct
readout. As a general statement, metabolic incorporation spans
from millisecond to hours based on the dynamic activity of a
given pathway plus the vicinity to the given substrate, and it
is affected by various factors, such as diffusion into tissues in
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ex vivo experiments or tissue availability in in vivo studies. For
a correct interpretation of the dynamic, we need to tune the
time points in order to have the initial phase of incorporation
as well as the late point of incorporation when the labeling
reaches a plateau. Combined together, the initial slope with
the total mobilized pool of each metabolite will give us the
possibility to evaluate the turnover rate, and therefore, assess
the kinetic of metabolic fluxes. The third point is linked to
the strategy that can be followed to minimize the perturbations
based on the type of experiments that are planned to be
performed. In this case, it is important to avoid alteration
of the nutrient factors during the experiment when possible.
As an example, in in vitro experiments, it is important to
work without varying the media composition between media
with or without labeled nutrients. This approach should be
preferred in favor of de-novo addition or supplementation of
the labeled substrate because the latter approach will change
the microenvironment in which the cells are growing, making
impossible to distinguish whether the dynamics observed are
linked to the microenvironment changes or not. It is also
important to minimize carryover between different conditions.
This possibility can be strictly avoided in vitro by choosing a
proper sample preparation strategy as previously discussed, but
not in ex vivo or in vivo experiments where this option should be
taken in to account when interpreting the data or by comparing
the substrate levels during the experiment e.g., in situ micro
dialysis (Watanabe et al., 2018).
In vivo Cell Metabolism
Questions:
How is the metabolism of a cell population or of a tissue in vivo?
Is the metabolism of a selected cell population or of a tissue changed
following different experimental paradigms or in diseases?
Cellular metabolism evaluation can be performed in vivo
by means of multimodal imaging modalities. This implies the
use of easily detectable probes tracking the metabolic activity
of groups of cells in living tissue. Based on the characteristics
of the probes or vehicles used, it is possible to apply
MRI (magnetic resonance imaging), MRS (magnetic resonance
spectroscopy) or PET (positron emission tomography) and
SPECT (single photon emission tomography). The resolution
of the abovementioned modalities decreases significantly while
passing from conventional MRI (0.12–0.24 mm) and PET
(1–3 mm) to SPECT (10 mm) and MRS (1–10 cm3; Blüml and
Panigrahy, 2013; Shah et al., 2013; Stucht et al., 2015). Higher
resolution levels can be instead achieved in animal studies by
means of micro-PET, SPECT and/or MRI (Koba et al., 2013).
Yet, none of these modalities is capable of imaging at the
cellular level.
In vivometabolic imaging with MRS allows the identification
of protons (1H) or other specific isotopes present in normal
compounds involved in the main metabolic pathways of
living cells: this is the case for instance of 17O (oxygen-17),
23Na (sodium-23), 19F (fluoride-19), and 31P (phosphor-31;
Herholz et al., 2007). One of the most well-known examples
is represented by MRS in the identification of tumor cells
thanks to the specific spectroscopic peaks of choline (Cho),
N-acetyl aspartate (NAA), lactate and/or the Cho-to-creatinine
(Cho/Cr) ratio that can be used as surrogate markers of
tumor growth and malignancy (Lopci et al., 2015). Choline
is a precursor of phosphatidylcholine, a component of the
cell membrane, directly related to cell-membrane turnover.
Typically, a choline peak reflects the presence of proliferative
tissue consistent with a glioma or malignant tumor (Lopci
et al., 2015). NAA is the second most abundant metabolite
in the central nervous system and is related to the synthesis
of neuropeptide N-acetylaspartylglutamate (NAAG), involved
in the neurotransmitter release and neuronal communication
(Moffett et al., 2006). Lactate is related to increased glucose
uptake and lack of oxygen supply, hence it becomes detectable
on MRS solely in tumor cells (Wang et al., 2017). Also,
creatinine is a marker of cellular energy metabolism and its
ratio to choline (Cho/Cr) tends to reflect the aggressiveness
or grade of tumor tissue (Herholz et al., 2007; Toyooka
et al., 2008). While using the same principle as mentioned
above, MRS can also lead to the molecular stratification
of tumors, such as gliomas, by searching very specific
metabolites along the pathway. This can be the case for
the oncometabolite 2-hydroxyglutarate, which serves as a
surrogate marker of the isocitrate dehydrogenase (IDH1 and
IDH2) mutation status (Choi et al., 2012). 1H-MRS has been
also used to identify metabolites enriched in rodent neural
stem cells and was used to indirectly quantify adult human
neurogenesis (Manganas et al., 2007).
Furthermore, diffusion-weighted MRS (DWI-MRS) has been
used for metabolic imaging. More precisely, it was introduced
to combine the in vivo exploration of intracellular structures
and physiology at the same time, allowing the detection and
quantification of the diffusion properties of the metabolites
involved (Valette, 2015). More recently, cell tracking with
superparamagnetic iron oxide has been applied to study other
cell types, including mesenchymal stem cells (Bengel, 2011). Iron
particles can be detected at micromolar concentrations, thus
permitting a very high resolution imaging of the cellular diffusion
(Bulte, 2009).
Cell tracking can also be performed by means of direct
labeling with radioactive nuclides for imaging in SPECT or PET
(Bengel, 2011). First, endothelial and hematopoietic progenitor
cells labeled with 111In-oxine, 99mTc-exametazime or 99mTc-
hexamethylpropyleneamine oxime (HMPAO), were used for
scintigraphic detection on SPECT, along with 2-deoxy-2-(18F)
fluoro-d-glucose (18F-FDG) for PET imaging (Aicher et al.,
2003; Bengel, 2011). During the process, blood and blood
components are taken from the patient and handled to isolate
the required cell line that needs to be labeled. All these
steps are extremely delicate and require caution to maintain
the cells alive after labeling with the radioactive tracer (de
Vries et al., 2010; Bengel, 2011). Imaging procedure will
allow the functional assessment of those specific cells within
the organs and tissue investigated. More broadly, metabolic
radiopharmaceuticals are used on PET to visualize both normal
and pathological mechanisms. Theoretically, all hallmarks of
stem or differentiated cell population can be detected with
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imaging by simply radiolabeling the molecule or the active
element (‘‘probe’’) in the focused pathway (Alam et al., 2015).
Also, labeled antibodies can be used to identify the component
characterizing the pathway. For instance, it is possible to image
CD133 expression in SCs by means of the detection of a
specific epitope called AC133, using the copper-64 labeled
PET compound 64Cu-labeled AC133-monoclonal antibody
(Gaedicke et al., 2014; Alam et al., 2015). As a non-invasive
imaging modality, PET can be applied in the preclinical and
clinical setting to measure site-specific accumulation of various
metabolic ‘‘probes’’ or radiopharmaceuticals (Laing et al., 2010;
Lopci et al., 2014, 2015; Figure 3).
The first and most widely used PET tracer is 18F-
FDG, a glucose analog labeled with fluoride-18. Similarly
to glucose, FDG is transported into the cells by means
of the facilitated diffusion glucose transporters (GLUTs),
and in particular GLUT1 (Navale and Paranjape, 2016).
Once inside, the tracer is phosphorylated by the enzyme
hexokinase (HK), which determines the entrapment of
18F-FDG within the cells (Laing et al., 2010). This process
is significantly increased in both anaerobic glycolysis (‘‘Pasteur
effect’’) and aerobic (‘‘Warburg effect’’; Lopci et al., 2014).
To study tissue oxygenation, it is possible to use the
PET tracers belonging to the fluorinated nitroimidazole
derivatives or nitroimidazole family compounds, such as
18F-fluoromisonidazole (18F-FMISO), 18F-fluoroazomycin
arabinoside (18F-FAZA), 18F-fluoroerythronitroimidazole
(18F-FETNIM), 18F-fluoroetanidazole (18F-FETA) and
18F-2-nitroimidazol-pentafluoropropyl acetamide (18F-EF5;
Lopci et al., 2014). Nitroimidazole family tracers are lipophilic
and diffuse passively through cell membrane. Once inside, they
are reduced into R-NO2 radicals by the nitroreductase enzyme
(NTR). When the cell is not oxygenated (pO2 <10 mmHg),
the reduction process continues to R-NHOH compounds that
bind covalently to intracellular molecules. This determines
the ultimate entrapment of the tracer in the cell (Lopci
et al., 2014). More peculiar tracers for hypoxia imaging
are represented by copper (60, 61, 62, 64 Cu) labeled
diacetyl-bis (N4-methylthiosemicarbazone; Cu-ATSM), which
follows another oxido-reductive process (Takahashi et al.,
2000), and radiolabeled antibody anti-carbonic anhydrase
IX (or CAIX), also known as antibody Grawitz250 (G250;
Takahashi et al., 2000). This later radiopharmaceutical tracks
CAIX, which is a transmembrane enzyme and one of the
downstream targets of hypoxia-inducible factors 1α (HIF-1α).
More specifically, its role is to hydrolyze the carbondioxide
(CO2) into carbonic acid (H2CO3) and stabilize intracellular
pH (Shuch et al., 2008).
Combined energetic and metabolic imaging can be offered by
other tracers used in PET (Figure 3). Radiolabeled carbon-11
acetate (11C-acetate) is one example of multifunctional tracers,
reflecting both oxidative metabolism and fatty acid synthesis
pathways. The molecule is transported into the normal cell
through the monocarboxylate transporter (MCT) and converted
in acetyl-CoA by the acetyl-CoA synthase (ACeS) present in
the cytosol and mitochondria (Klein et al., 2001; Croteau et al.,
2016). In the cytosol, acetyl-CoA pathway leads to the synthesis
of cholesterol and fatty acids, which are incorporated into cell
membranes, while in the mitochondria, it leads to complete
oxidation to 11C-CO2 and H2O (Lopci and Fanti, 2013). The
higher the Krebs cycle activity, the higher 11C-acetate clearance.
The tracer can also be used as a marker of fatty acid synthase,
a key enzyme for oxidative metabolism and fatty acid synthesis
pathway (Witney et al., 2014; Croteau et al., 2016).
Another key element for the evaluation of membrane
phospholipids is represented by radiolabeled choline (18F- or
11C-choline), which is the precursor of phosphatidylcholine
(Zeisel, 1981). The molecule is an essential component also
for the synthesis of neurotransmitters, such as acetylcholine,
or lipid mediators, such as platelet-activating factor (Challapalli
and Aboagye, 2016). It is rapidly taken up into the cell by the
choline transporter (CHT) and phosphorylates by CHK (Choline
kinase) to phosphocholine (P-Choline). P-Choline is further
phosphorylated by the enzyme cytidylyltransferase to cytidine
diphosphate-choline (CDP-choline) and other metabolites until
it is incorporated into the cell membrane (Gibellini and Smith,
2010). In highly proliferative cells, the uptake of radiolabeled
choline reflects the levels of membrane turn-over, which is
associated with increased choline transport and utilization, due
to the increased CHK expression in undifferentiated and stem
cells (Jansen et al., 2006; Glunde et al., 2011; Challapalli and
Aboagye, 2016).
Cellular proliferation is visible directly by means of
the fluorinated thymidine analog 18F-3′-deoxy-3′-18F-
fluorothymidine (18F-FLT). This tracer enters the cell
by means of the nucleoside transporters (NTs) and is
then phosphorylated by the enzyme thymidine kinase 1
(TK1). This process determines the entrapment of the
tracer within the cell and its uptake is a direct reflection
of the TK1 activity and cellular S-phase, since FLT, unlike
thymidine, is only marginally (<2%) incorporated into the
DNA chain (Been et al., 2004). 18F-FLT uptake correlates with
Ki-67 (Croteau et al., 2016).
Amino acid metabolism found several representatives in
PET imaging. Radiolabeled methionine (11C-L-methyl-11C-
methionine, 11C-MET) or tyrosine (18F-fluoroethyltyrosine,
18F-FET) are two of the most widely used compounds with
this regard. These molecules are transported in the cell via the
large amino transporter (LAT1) and once inside, their uptake
reflects proteinmetabolism (Lopci et al., 2014, 2015).Metabolism
of methionine and tyrosine greatly affect SC biology, including
iPSC stemness and differentiation potential (Shiraki et al., 2014)
and mesenchymal stem cells (Higuera et al., 2012). Tracer
accumulation in the differentiated brain cells is almost negligible
and significantly increases in proliferating cells, such as glioma-
initiating cells (Law et al., 2019).
Other molecules, like 18F-dihydroxyphenylalanine (18F-
DOPA), follow the same transportation within the cell as
11C-MET or 18F-FET, although 18F-DOPA is not simply
an amino acid but also a precursor for catecholamine
metabolism, and therefore, quite relevant for a subset of neuronal
populations (Koopmans et al., 2009). Once inside the cell,
18F-DOPA is decarboxylated via the enzyme aromatic acid
decarboxylase (AADC) to 18F-dopamine, which is probably
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FIGURE 3 | Summary of selected metabolic pathways detectable non-invasively with radiolabeled compounds applicable with PET imaging in clinical practice.
Abbreviations: Cu-ATSM, Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone; F-MISO, fluoromisonidazole; FAZA, Fluoroazomycin Arabinoside; MAT, monoamine
transporter; MET, methionine; FET, fluoroethyltyrosine; LAT, large amino acid transporter; F-DOPA, fluoro-3,4-dihydroxyphenylalanine; AA-pool, amino acid pool; FLT,
Fluorothymidine; NTs, nucleoside transporter families; TK1, thymidine kinase-1; TMP, thymidine monophosphate; CHO, choline; CHT, choline transporter; ChoK,
choline kinase; P-choline, phosphocholine; ACE, acetate; MCT, monocarboxylate transporter; FDG, fluorodeoxyglucose; GLUT, glucose transporter; HK, hexokinase;
FDG-6-P, fluorodeoxyglucose-6-phosphatase.
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then transported into secretory vesicles by vesicular monoamine
transporter (VMAT; Luxen et al., 1992). Catecholamine and
their intermediate products, such as dopamine or serotonine
and their radiolabeled forms, enter directly into the secretory
vesicles after being transported in the cell through the MCT
system (Figure 3).
Oxygen Consumption Rate (OCR) and
Biosensors
Mitochondrial function greatly impacts SC metabolism being
crucial for the instruction of quiescence, proliferation and
differentiation processes. OCR can be assessed on isolated
mitochondria, tissue homogenate, permeabilized tissue,
living cells and tissues (Kelly et al., 2013). Current available
methods measure oxygen concentration of the sample over
time (oxygraphy). Firstly invented by Clark in 1953 (Clark et al.,
1953), sophisticated highly sensitive Clark type oxygen electrodes
are now capable of minimizing oxygen diffusion, allowing the
instantaneous on-line recording of OCRs (Gnaiger et al., 1995).
Such devices, including Oroboros Oygraph, can simultaneously
measure oxygen consumption and fluorometric signals,
thus providing a valuable tool for coupling high-resolution
respirometry with other mitochondrial functions, including
ROS and ATP production, mitochondrial membrane potential
and mitochondrial Ca2+concentration (Doerrier et al., 2018).
Other available methods quantify extracellular OCR. The
extracellular flux (XF) analyzer instrument (e.g., Seahorse
XF24) measures extracellular oxygen consumption by sampling
an extremely small volume (about 2 µL) of medium over
time, above a monolayer of cells or tissue slices within a petri
dish. XF analyzer allows real-time measurements of oxygen
consumption by using solid-state fluorescent oxygen biosensors
coupled with highly sensitive photodetectors specific for the
excitation and emission of oxygen (532/650 nm; Wu et al.,
2007). Sequential addition of drugs impairing mitochondrial
complex functions, such as complex V inhibitor (i.e., ATP
synthase, oligomycin), oxidative phosphorylation uncoupler
(FCCP) and complex III and I inhibitors (antimycin A and
rotenone), provides information on: (i) the amount of oxygen
consumed for ATP production; (ii) basal and the maximal
respiration rates; (iii) spare respiratory capacity; (iv) the
fraction of oxygen not used for ATP production (proton
leak); and (v) the non-mitochondrial oxygen consumption
(Salabei et al., 2014). The main limitation of these methods
is that they cannot provide any information on the specific
metabolic flux (i.e., glucose, glutamine or FAO) contributing
to the overall oxygen consumption. Recently, these methods
have been proposed for assessing the capability of cultured
cells to oxidize specific substrates (i.e., increase oxygen
consumption following palmitic acid overload). This measure
has been proposed to estimate the metabolic flux for the
tested metabolite. However, it only provides a measure of
the potential oxidative capability for that metabolite. More
precisely, it cannot answer the question as to how much
the FAO contributes to a given oxygen consumption. On
the contrary, it can give information about how much the
tested cell type can maximally oxidize a given substrate.
To study the relative contribution of specific metabolic
fluxes to the overall oxidative metabolism, the metabolic
flux analysis is required.
To study real-time metabolism at a single cell level in
living samples, fluorescent metabolic biosensors that are able
to bind functional state to a fluorescence protein activity have
been developed (Mongeon et al., 2016). Genetically encoded
fluorescence and fluorescence resonance energy transfer (FRET)
reporters allow real-timemeasurement of the selectivemetabolite
concentrations and fluxes in intact cells both in vitro and
in vivo. The genetically encoded biosensor Peredox specific
to the NADH:NAD+ couple, allows to visualize the cytosolic
NADH:NAD+ redox state in cells or tissues using two-photon
fluorescence lifetime imaging microscopy (Mongeon et al.,
2016). Cytosolic NAD+ is converted to NADH during glycolysis
by the glyceraldehyde-3-phosphate dehydrogenase. Moreover,
NADH:NAD+ ratio responds to lactate dehydrogenase activity in
the cytosol and to mitochondrial NADH shuttles. Interestingly,
the fluorescence lifetime of this sensor protein is very short
(nanoseconds) giving a direct report of cytosolic NADH:NAD+
ratio (Hung et al., 2011). This probe has been used successfully
to measure the increase of neuronal glycolysis triggered by
neuronal electrical stimulation (Díaz-García et al., 2017).
Similarly, the genetically encoded FRET lactate sensor Laconic
allows for monitoring of cellular or tissue lactate dynamics
(Machler et al., 2016). The transduction of such probes,
driven by the tissue-specific promoters, allows the detection
of cell metabolism in a defined subset of cells. Laconic
probe was used to study in vivo lactate metabolism in
astrocytes (Mulder et al., 2016). Laconic was transduced in
the primary somatosensory cortex of mice using a viral
vector driven by GFAP promoter and therefore expressed in
the cytoplasm of protoplasmic cortical astrocytes (Machler
et al., 2016). The genetically encoded biosensor Pyronic is
a FRET sensor capable of quantitatively measuring pyruvate
transport, pyruvate production and mitochondrial pyruvate
consumption in living single cell at high temporal resolution.
Pyronic has been used in different cell types in vitro and
ex vivo (i.e., HEK293 cells, neurons and astrocytes; San
Martín et al., 2014; Lerchundi et al., 2015; Baeza-Lehnert
et al., 2019). Central for the understanding of stem and
differentiated cell metabolism is the real-time estimation of
ATP:ADP ratio. The genetically-encoded fluorescent biosensor,
PercevalHR, senses the range of intracellular ATP:ADP (Berg
et al., 2009), and it can be used with one- or two-photon
microscopy in live samples (Tantama et al., 2013). Similarly
to PercevalHR, the ATeam FRET-based biosensors allow for
visualizing ATP levels inside a single living cell (Imamura
et al., 2009). Both Perceval and ATeam biosensors are sensitive
reporters of physiological changes in energy consumption
and production and can provide an accurate and real-time
estimation of ATP variations when cells are exposed to
multiple stimuli (Tantama et al., 2013; Trevisiol et al., 2017).
Transgenic mice genetically engineered to produce fluorescent
metabolic biosensors in all cells or in specific cell types
are now available (Trevisiol et al., 2017). These reporter
mice are of great interest to study real-time metabolism
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at single cell level in living animal (Trevisiol et al., 2017;
Baeza-Lehnert et al., 2019).
Biosensors are of great interest for the understanding
of cellular metabolism. The major limitation of this novel
technique, however, is that it needs gene transfer of the probe,
being potentially utilized only in preclinical animal models.
Moreover, such in vivo studies require accessibility of the tissue
for two-photon imaging.
CONCLUSION AND PERSPECTIVE
Despite the plethora of methods and protocols that have been
published in the last decade, only a limited selection of them are
compatible with the constraints imposed by SCs and are therefore
suitable for accurate SC metabolic analysis. Both targeted and
untargeted approaches provide valuable tools to describe and
analyze the cellular metabolism of a specific stem cell population.
Given the fast dynamic of intracellular metabolism, the available
techniques for sorting (i.e., FACS or immunomagnetic)
homogeneous cell population, from a tissue or from a cell
suspension, require too long procedures. Therefore, the major
limitation is to resolve the characterization of cellularmetabolism
at the single cell level.While single-cell metabolomics approaches
allow, avoiding cell isolation and cell lysis, the measure of SC
metabolism, most of the current methodologies, including MS
and RMN, require cell separation. Therefore, they provide
relevant information on SC metabolism mostly in vitro when
homotypic SC population are examined. The identification and
quantification of specific SC population in vivo may be possible
using MRS if peculiar metabolites are uniquely enriched in
such distinct SC type (Manganas et al., 2007). Furthermore,
the development of new biosensors will allow the real-time
detection of several metabolites and metabolic fluxes at a single
cell level in living samples. The assessment of the modification
of the cellular metabolism with time within a certain cell
population will also provide important and potentially
exploitable information. It would be of great advantage to
follow intracellular metabolic adaptation in real time when a
defined experimental condition is applied. A further level of
analysis will be the assessment of a specific metabolic signature
or flux in a subset of cellular compartments, such as lamellipodia
(De Bock et al., 2013), lysosome (Abu-Remaileh et al., 2017;
Wolfson et al., 2017), mitochondria (Yoshida et al., 2017) or
cytoplasm (Pan et al., 2018).
The combination of the different methodologies available
nowadays provides wide equipment for the study of cellular
metabolism of quiescent, proliferating and differentiating stem
cells. Generation of new knowledge on cellular metabolism will
hopefully generate novel therapeutic strategies capable of driving
specific and desired cellular phenotype.
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